Low Preoperative Serum Albumin Levels Are Associated With Impaired Outcome After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
- PMID: 33447310
- PMCID: PMC7781284
- DOI: 10.14740/jocmr4362
Low Preoperative Serum Albumin Levels Are Associated With Impaired Outcome After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
Abstract
Preoperative hypoalbuminemia is known to be associated with postoperative morbidity and mortality, as well as with poor survival after gastrointestinal cancer surgery. However, limited data exist regarding the prognostic significance of hypoalbuminemia in patients with peritoneal metastases undergoing cytoreductive surgery, combined with perioperative intraperitoneal chemotherapy. We performed a systematic literature review of the previously published studies addressing the potential association between preoperative albumin levels and overall surgical outcomes after the performance of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancies. Our research yielded a total of nine retrospective studies which met our inclusion criteria, and despite their heterogeneity; and we can conclude that preoperatively low albumin levels are associated with greater likelihood of overall and major morbidity, as well as less favorable oncological outcome after the performance of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Keywords: Albumin; Cancer; Cytoreductive surgery; HIPEC; Intraperitoneal chemotherapy; Nutrition; Peritoneal malignancy.
Copyright 2020, Seretis et al.
Conflict of interest statement
None to declare.
Figures
Similar articles
-
Impacts of Preoperative Serum Albumin Level on Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.Ann Surg Oncol. 2016 Aug;23(8):2411-8. doi: 10.1245/s10434-016-5172-9. Epub 2016 Mar 8. Ann Surg Oncol. 2016. PMID: 26957502
-
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456. Dis Colon Rectum. 2019. PMID: 31490828
-
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.J Clin Oncol. 2004 Aug 15;22(16):3284-92. doi: 10.1200/JCO.2004.10.012. J Clin Oncol. 2004. PMID: 15310771
-
Urinary tract involvement in peritoneal metastatic disease: Is this a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?J BUON. 2017 Mar-Apr;22(2):301-305. J BUON. 2017. PMID: 28534348 Review.
-
[Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].Orv Hetil. 2006 Jan 29;147(4):147-58. Orv Hetil. 2006. PMID: 16515023 Review. Hungarian.
Cited by
-
Albumin Leakage Level during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Major Complications.Cancers (Basel). 2024 Aug 19;16(16):2874. doi: 10.3390/cancers16162874. Cancers (Basel). 2024. PMID: 39199645 Free PMC article.
-
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing cytoreductive surgery: a retrospective study.Front Nutr. 2024 May 3;11:1364959. doi: 10.3389/fnut.2024.1364959. eCollection 2024. Front Nutr. 2024. PMID: 38765813 Free PMC article.
-
Risk factors and clinical impact of seroma formation following laparoscopic inguinal hernia repair: a retrospective study.BMC Surg. 2024 Oct 1;24(1):274. doi: 10.1186/s12893-024-02574-1. BMC Surg. 2024. PMID: 39354429 Free PMC article.
-
Albumin: a comprehensive review and practical guideline for clinical use.Eur J Clin Pharmacol. 2024 Aug;80(8):1151-1169. doi: 10.1007/s00228-024-03664-y. Epub 2024 Apr 12. Eur J Clin Pharmacol. 2024. PMID: 38607390 Review.
References
-
- Sugarbaker PH. Management of peritoneal metastases - Basic concepts. J BUON. 2015;29(Suppl 1):S2–11. - PubMed
-
- Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900–907. doi: 10.1097/SLA.0b013e3181a45d86. - DOI - PubMed
-
- Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL. et al. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014;101(13):1758–1765. doi: 10.1002/bjs.9674. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous